Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT06260124
Other study ID # Greek Dancing-UTH
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date April 10, 2024
Est. completion date October 30, 2024

Study information

Verified date June 2024
Source University of Thessaly
Contact Dimitrios Draganidis, PhD
Phone 2431047078
Email ddraganidis@uth.gr
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

In Greece, people of different age groups, including young children to older adults, are involved in traditional dance. To date, the well-know benefits of dancing include entertainment, socialization and increased physical activity. However, the acute effects of Greek traditional dancing on health, physical performance and muscle damage indices remain largely unknown. Therefore, the aim of this project is to evaluate the acute effect of Greek traditional dancing on health-, physical performance-, and muscle damage-related parameters by considering the impact of dancing tempo (slow vs moderate vs fast). In a crossover repeated measures design 10 pre- and 10 post-menopausal women will participate in the three dancing sessions of different tempo in a random order.


Description:

This study aims at determining the acute effect of Greek traditional dancing on health- and physical performance-related parameters by considering the impact of dancing tempo. Ten pre- and ten postmenopausal women meeting the inclusion criteria will be assigned to a crossover trial. Initially, participants will undergo baseline testing including (i) anthropometrics, (ii) body composition, (iii) physical performance, (iv) physical activity level and (v) dietary intake. After baseline measurements, a 7-day familiarization period will take place, during which participants will practice daily on the three experimental dances. Each dance will be characterized by a different tempo (beats per minute) so that there will be one dance from each tempo category (i.e. slow, moderate and fast). After familiarization, participants will execute in a random order the three dancing sessions, on separate days. Each dancing session will consist of one dance (of either slow or moderate or fast tempo) lasting ~ 3- 4 minutes. During each dance heart rate, oxygen consumption and activity intensity will be continuously monitored. Before and immediately after the dance systolic and diastolic blood pressure, perceived exertion and blood lactate will be measure. In addition, before each dance and at 24 and 48 hours post-dance muscle soreness, muscle strength and resting metabolic rate will be measured and a resting blood sample will be drawn for the assessment of inflammatory and oxidative stress markers.


Recruitment information / eligibility

Status Recruiting
Enrollment 20
Est. completion date October 30, 2024
Est. primary completion date June 30, 2024
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 20 Years to 80 Years
Eligibility Inclusion Criteria: - Premenopausal and postmenopausal women. - Abstain from vigorous physical activity and/or exercise during the last (at least) 6 months prior to the study. - Free of musculoskeletal diseases and injuries. - Free of cardiometabolic diseases. - Free of mental health disorders - No body weight loss >10% over the last 6 months prior to the study - Non-smokers Exclusion Criteria: - Perimenopause and menopause women - Participation vigorous physical activity and/or exercise during the last (at least) 6 months prior to the study - Presence of musculoskeletal diseases and injuries. - Presence of cardiometabolic diseases. - Presence of mental health disorders - Body weight loss >10% over the last 6 months prior to the study - Smokers

Study Design


Intervention

Other:
Slow tempo
A single Greek traditional dance of slow tempo lasting 3-4 minutes.
Moderate tempo
A single Greek traditional dance of moderate tempo lasting 3-4 minutes.
Fast tempo
A single Greek traditional dance of fast tempo lasting 3-4 minutes.

Locations

Country Name City State
Greece University of Thessaly, Department of Physical Education and Sport Science Tríkala Thessaly

Sponsors (1)

Lead Sponsor Collaborator
University of Thessaly

Country where clinical trial is conducted

Greece, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change in blood pressure Systolic and diastolic blood pressure will be measured using a blood pressure cuff At baseline and immediately after the dance
Primary Change in perceived exertion Perceived exertion will be rated using the Borg Rating of Perceived Exertion scale, a numerical scale that ranges from 6 (no exertion) to 20 (maximum effort). At baseline and immediately after the dance
Primary Change in blood lactate Blood lactate will be measured on a portable, automatic lactate analyser using the relevant strips At baseline and immediately after the dance
Primary Change in resting metabolic rate Resting metabolic rate (kcal) will be assessed using a portable open-circuit indirect calorimeter with a ventilated hood system At baseline and at 24 hours and 48 hours after the dance
Primary Change in delayed-onset of muscle soreness (DOMS) DOMS of the knee extensors and flexors of both limbs will be evaluated by palpation of the relaxed muscle's belly and distal region with participants rating the perceived soreness on a visual analogue scale ranging from 1 to 10. At baseline and at 24 hours and 48 hours after the dance
Primary Change in maximal isometric voluntary contraction Maximal isometric voluntary contraction of the knee extensors and flexors of both limbs will be assessed using an isokinetic dynamometer. At baseline and at 24 hours and 48 hours after the dance
Primary Change in joint range of motion Knee joint range of motion will be assessed using a manual goniometer At baseline and at 24 hours and 48 hours after the dance
Primary Change in functional performance Functional performance will be assessed using the movement-based screening tool functional movement screen (FMS) At baseline and at 24 hours and 48 hours after the dance
Primary Change in white blood cell count White blood cell count will be measured using an automatic blood analyzer At baseline and at 24 hours and 48 hours after the dance
Primary Change in granulocyte count Granulocyte count will be measured using an automatic blood analyzer At baseline and at 24 hours and 48 hours after the dance
Primary Change in lymphocytes Lymphocytes will be measured using an automatic blood analyzer At baseline and at 24 hours and 48 hours after the dance
Primary Change in monocytes Monocytes will be measured using an automatic blood analyzer At baseline and at 24 hours and 48 hours after the dance
Primary Change in creatine kinase concentration Creatine kinase will be measured using an automatic blood analyzer and commercially available kits At baseline and at 24 hours and 48 hours after the dance
Primary Change in reduced glutathione Reduced glutathione will be measured spectrophotometrically in red blood cells At baseline and at 24 hours and 48 hours after the dance
Primary Change in oxidized glutathione Oxidized glutathione will be measured spectrophotometrically in red blood cells At baseline and at 24 hours and 48 hours after the dance
Primary Change in catalase activity Catalase activity will be measured spectrophotometrically in red blood cells At baseline and at 24 hours and 48 hours after the dance
Primary Change in protein carbonyls Protein carbonyls will be measured spectrophotometrically in red blood cells At baseline and at 24 hours and 48 hours after the dance
Primary Change in total antioxidant capacity Total antioxidant capacity will be measured spectrophotometrically in plasma At baseline and at 24 hours and 48 hours after the dance
Primary Change in heart rate Heart rate will be continuously monitored using heart rate sensors Through dance session completion, an average of 30 minutes
Primary Change in oxygen consumption Oxygen consumption will be continuously monitored using a portable metabolic system. Through dance session completion, an average of 30 minutes
Primary Change in physical activity The number of steps performed will be assessed using an accelerometer (ActiGraph Gt3x) Through dance session completion, an average of 30 minutes
Secondary Change in red blood cell count Red blood cell count will be measured using an automatic blood analyzer At baseline and at 24 hours and 48 hours after the dance
Secondary Change in hematocrit Hematocrit will be measured using an automatic blood analyzer At baseline and at 24 hours and 48 hours after the dance
Secondary Change in hemoglobin Hemoglobin will be measured using an automatic blood analyzer At baseline and at 24 hours and 48 hours after the dance
See also
  Status Clinical Trial Phase
Completed NCT04553029 - A Survey Evaluating Prevalence, Severity and Associated Factors in East Asian Women With Moderate-to-severe Menopause-related Vasomotor Symptoms (MR-VMS)
Completed NCT03672513 - Short-term Supplementation, Bone Turnover and Antioxidant Status in Menopause N/A
Terminated NCT03642119 - Validation of an Objective Instrument to Measure Hot Flashes During Menopause
Completed NCT05387174 - Nursing Intervention in Two Risk Factors of the Metabolic Syndrome and Quality of Life in the Climacteric Period N/A
Completed NCT04210583 - RF and PEMF for Treatment of Vaginal Laxity and Mons Pubis and Labia for Improvement of Skin Laxity N/A
Completed NCT06057896 - Effects of Combined Natural Molecules on Metabolic Syndrome in Menopausal Women
Completed NCT05617287 - An Exploratory Investigation of Dietary Supplementation and the Effect on Common Symptoms of Perimenopause and Menopause N/A
Recruiting NCT05180266 - Therapeutic Touch and Music in The Menopausal Period N/A
Recruiting NCT04043520 - Bioenergetic Effects of Aging and Menopause (BEAM) Phase 4
Completed NCT03663075 - Effect of Group Education and Individual Counselling on Mental Health and Quality of Life in 45-60 Year Old Women N/A
Completed NCT03363997 - Pharmacokinetics and Pharmacodynamics of 3 Dosages of Estriol After Continuous Vaginal Administration for 21 Days Phase 1
Not yet recruiting NCT04724135 - Assessment of Menopause Related Quality of Life Among Health Professionals in University Hospitals of UMC in Nur-Sultan
Not yet recruiting NCT04728126 - Menopausal Symptoms and Burnout: Comparison of Occupational Health Issue Among Health Professionals in UMC Hospitals
Completed NCT02274571 - Raising Insulin Sensitivity in Post Menopause Early Phase 1
Completed NCT02430987 - Low Sexual Desire and Metabolic Syndrome N/A
Completed NCT02253173 - Estradiol Vaginal Softgel Capsules in Treating Symptoms of Vulvar and Vaginal Atrophy in Postmenopausal Women Phase 3
Completed NCT01757340 - Calorie Restriction With Leucine Supplementation N/A
Recruiting NCT01488903 - A Cohort Research of Genetic Susceptibility for Common Obesity in Women N/A
Terminated NCT01633814 - Hormone Replacement and Neural Cardiovascular Control in Postmenopausal Women N/A
Completed NCT00599456 - Investigation of the Usefulness of Omega 3 Vitamins in the Relief of Hot Flashes in Menopausal Women. N/A